MODIFIED FORMULATION OF FEBUXOSTAT: IMPROVED EFFICACY AND SAFETY

Abstract

Objective: Febuxostat, a xanthine oxidoreductase inhibitor, is a drug of choice for hyperuricemia and Gout. But it also suffers from drawbacks in terms of pharmacokinetic profile and toxicity. It is available as immediate release formulation in the market. The objective is to develop a modified release formulation of febuxostat that can serve the dual purpose of increasing the efficacy and decreasing the toxicity, thereby improving safety.Methods: Pharmacokinetic and pharmacodynamic data, including drug concentration profile, efficacy data and toxicity data have been reviewed thoroughly. Based on available data, target pharmacokinetic profile has been identified as about 50 % reduction in Cmax and improvement in plasma drug concentration above required level during 6-24 hour. Desired in-vitro dissolution profile has been selected, and formulation modification has been sought to achieve the desired profile. The formulation has been prepared with a partial dose in the form of immediate release (IR) and remaining dose as an extended release (ER). IR and ER formulations have been developed separately and combined to form Inlay tablets containing ER inner tablet surrounded by IR.Results: Based on dissolution data and Wagner-Nelson calculations, the plasma concentration profile has been predicted for the developed formulation. It reconfirms that developed formulation will achieve the desired objectives. Formulation stability has been established up to 6 months under accelerated conditions.Conclusion: The developed formulation is a potential candidate for filing to a regulatory agency with the advantage of higher efficacy and less toxicity, which will be beneficial to the patient population and has good commercial viability. 

Authors and Affiliations

Ketan Savjani, Anuradha Gajjar, Jignasa Savjani

Keywords

Related Articles

USE OF SOME ETHNOMEDICINAL HERBS BY THE NATIVES OF SOLANG VALLEY, KULLU DISTRICT, HIMACHAL PRADESH

Objective: The objective of the study was to enlist the ethnobotanical uses of wild plants of Solang Valley, Kullu District, Himachal Pardesh. Due to the specific geographical location of the valley, it possesses a high...

LANNEA BARTERI ENGL. (ANACARDIACEAE) PLANT USED IN THE TREATMENT OF URINARY TRACT INFECTIONS IN IVORY COAST: BIOLOGICAL AND CHEMICAL STUDIES OF THE AQUEOUS EXTRACT

Objective: This research aims to evaluate the antibacterial activity and determine the chemical composition of the aqueous extract of the bark of Lannea barteri Engl. (DA) used in the traditional treatment of urinary tra...

A PROSPECTIVE OBSERVATIONAL STUDY ON RISK ASSESSMENT OF STEMI PATIENTS AT A TERTIARY CARE HOSPITAL

Objectives: To estimate risk of mortality and morbidity of STEMI patients at admission and discharge time. One objective includes comparing the lipid profile in STEMI patients and healthy subjects to establish the relati...

EPIDEMIOLOGY AND OUTCOME AMONG SEVERE SEPSIS AND SEPTIC SHOCK PATIENTS IN A SOUTH INDIAN TERTIARY CARE HOSPITAL

Objective: The objective of this research was to determine the prevalence of severe sepsis and septic shock and evaluate its outcome.Methods: This was a prospective, observational study, in which adult patients with seve...

SIMPLE HPLC-UV METHOD FOR DETERMINATION OF METFORMIN IN HUMAN PLASMA AND ERYTHROCYTES APPLICATION TO THERAPEUTIC DRUG MONITORING

Objective: The aim of this study was to develop a simple, rapid, efficient, cost effective and reproducible, stability indicating reverse phase high performance liquid chromatography method (RP-HPLC) for dosage of metfor...

Download PDF file
  • EP ID EP577969
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Ketan Savjani, Anuradha Gajjar, Jignasa Savjani (2016). MODIFIED FORMULATION OF FEBUXOSTAT: IMPROVED EFFICACY AND SAFETY. International Journal of Pharmacy and Pharmaceutical Sciences, 8(1), 359-366. https://europub.co.uk/articles/-A-577969